| Followers | 694 |
| Posts | 31930 |
| Boards Moderated | 7 |
| Alias Born | 03/16/2014 |
Thursday, June 15, 2023 1:38:42 PM
OGI ~OrganiGram "KEY INTERNATIONAL SUPPLY ARRANGEMENTS"...
• $5.9 million of flower revenue in Q1 F23, growing 71% from $3.4 million in Q1 F22
• High margin and not subject to excise tax
• Continued supply of dried flower to Canndoc for processing and distribution into Israeli medical
market1
• November 17, 2022: entered into a new multi-year Strategic Agreement with Canndoc to
supply up to 20,000kg of dry flower to Israel
• Opportunity to launch Organigram-branded medical products in Israel, and grants exclusivity
and related rights to Canndoc in Israel market
• Continued shipments made to Medcan and Cannatrek in Australia
The above information is located in OrganiGram's "Investor Presentation" download Page 28.
https://investors.organigram.ca/sites/default/files/documents/ogi_investors_Q1_2023_0.pdf
.
• $5.9 million of flower revenue in Q1 F23, growing 71% from $3.4 million in Q1 F22
• High margin and not subject to excise tax
• Continued supply of dried flower to Canndoc for processing and distribution into Israeli medical
market1
• November 17, 2022: entered into a new multi-year Strategic Agreement with Canndoc to
supply up to 20,000kg of dry flower to Israel
• Opportunity to launch Organigram-branded medical products in Israel, and grants exclusivity
and related rights to Canndoc in Israel market
• Continued shipments made to Medcan and Cannatrek in Australia
The above information is located in OrganiGram's "Investor Presentation" download Page 28.
https://investors.organigram.ca/sites/default/files/documents/ogi_investors_Q1_2023_0.pdf
.
Bullish
Recent OGI News
- Cannabis Revenue Decline Pressures Organigram Earnings Despite Germany Expansion (OGI) • IH Market News • 05/12/2026 03:05:50 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/12/2026 11:43:15 AM
- Organigram Reports Second Quarter Fiscal 2026 Results • Business Wire • 05/12/2026 10:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/06/2026 07:28:49 PM
- Organigram to Report Second Quarter Fiscal 2026 Results on May 12th, 2026 • Business Wire • 05/06/2026 10:00:00 AM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 04/17/2026 12:33:10 PM
- Organigram Closes Previously Announced Acquisition of Sanity Group, Private Placement Financing with BAT and ATB Senior Secured Credit Facilities • Business Wire • 04/15/2026 04:03:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/31/2026 01:55:58 AM
- Organigram Announces Shareholder Approval of Acquisition of Sanity Group GmbH and Results of its Annual General and Special Meeting • Business Wire • 03/31/2026 12:30:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/23/2026 02:10:09 PM
- Organigram Announces Independent Proxy Advisory Firm ISS Recommends Organigram Shareholders Vote FOR the Acquisition of Sanity Group GmbH • Business Wire • 03/23/2026 10:00:00 AM
- Organigram Announces Mailing of Management Information Circular in Connection with Annual General and Special Meeting • Business Wire • 03/10/2026 10:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/09/2026 09:14:50 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/05/2026 05:27:39 PM
- Organigram Global Expands FAST™ Innovation Platform with SHRED Shotz, Leveraging SHRED Brand Equity • Business Wire • 03/05/2026 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/03/2026 05:23:16 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/24/2026 04:18:03 PM
- Organigram Further Expands Global Portfolio with Launch of Edison and BOXHOT Medical Vapes and Pastilles in Australia • Business Wire • 02/24/2026 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/20/2026 09:58:07 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/19/2026 07:21:54 PM
- Organigram Announces C$65.2 Million BAT Private Placement Investment in Connection with the Acquisition of Sanity Group • Business Wire • 02/19/2026 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/18/2026 03:40:13 PM
- Organigram Announces Proposed Acquisition of Sanity Group, a Leading German Cannabis Company • Business Wire • 02/18/2026 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/10/2026 12:41:44 PM
